<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">KAOLIN AND PECTIN</span><br/>(kay'oh-lin and pek'tin)<br/><span class="topboxtradename">Kaolin w/Pectin<br/></span><b>Classifications:</b> <span class="classification">gastrointestinal agent</span>; <span class="classification">antidiarrheal</span><br/><b>Prototype: </b>Loperamide<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>5.2 g Kaolin/260 mg pectin/30 mL, 90 g Kaolin/2 g pectin/30 mL</p>
<h1><a name="action">Actions</a></h1>
<p>Kaolin is hydrated aluminum silicate. Efficacy of kaolin or pectin in diarrhea is not clearly established.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Kaolin is reported to have adsorbent, protectant, and demulcent properties. Mechanism of action of pectin may help consolidate
         stool.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Adjunct in symptomatic treatment of mild to moderately severe acute diarrhea. Commonly used in antidiarrheal combination products.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Suspected obstructive bowel lesion, pseudomembranous colitis, diarrhea associated with bacterial toxins; presence of fever;
         use for more than 48 h without medical direction. Safety during pregnancy (category C) or lactation is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Infants or children <img src="../images/special/lesserorequal.gif"/>3 y, older adults.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Diarrhea</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 60120 mL of regular suspension or 4590 mL of concentrated suspension after each loose bowel movement<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span>
<i>35 y</i>, 1530 mL regular suspension or 15 mL concentrated suspension after each loose bowel movement; <i>611 y</i>, 3060 mL regular suspension or 30 mL concentrated suspension after each loose bowel movement; <img src="../images/special/greaterorequal.gif"/><i>12 y</i>, 60 mL regular suspension or 45 mL concentrated suspension after each loose bowel movement<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Administer at least 24 h before other oral medications.</li>
<li>Shake suspension well before pouring.</li>
<li>Store in tightly closed container at 15°30° C (59°86° F) unless otherwise directed. Protect
            from freezing.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">GI:</span> Constipation usually mild and transient. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Chloroquine,</b>
<b>digoxin,</b>
<b>penicillamine,</b>
<b>tetracycline,</b>
<b>ciprofloxacin,</b> and most other drugs. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Not absorbed from GI tract. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Assess for abdominal distension and number of stools per day.</li>
<li>
            							Note: Fecal impaction may result from taking kaolin and pectin, especially in older adults.
            						
         </li>
<li>
            							Note: Drug may decrease absorption of any orally administered medication.
            						
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not to exceed prescribed dosage.</li>
<li>Notify physician if diarrhea is not controlled within 48 h or if fever develops.</li>
<li>Do not breast feed infants while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>